midpage
Projects
Sign in to see your projects.
119 F.4th 27
Fed. Cir.
2024
Read the full case

Background

  • AlexSam, Inc. holds the now-expired U.S. Patent No. 6,000,608 for a multifunction card system involving a processing hub and multiple databases for different card functions (e.g., debit and medical services).
  • AlexSam sued Aetna in the District of Connecticut, alleging Aetna’s Mastercard- and VISA-branded products infringed claims 32 and 33 of the ’608 patent.
  • A key factor is a 2005 license agreement between AlexSam and Mastercard—which Aetna claims gives it a sublicense to any alleged infringement via Mastercard products.
  • The district court dismissed AlexSam’s complaint, primarily based on the license agreement as an affirmative defense (Mastercard Products), and found insufficient direct/indirect infringement allegations regarding VISA Products.
  • AlexSam appealed, arguing the district court misconstrued the scope of the license and failed to credit its factual allegations as required at the motion to dismiss stage.
  • The Federal Circuit reviewed de novo the district court’s dismissal under Rule 12(b)(6).

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Scope of License covering Mastercard Products License does not cover all alleged infringing activities All Mastercard-related activities are fully licensed License only covers activation/adding value transactions; not all acts are licensed. Dismissal vacated & remanded.
Plausible direct infringement by Aetna using VISA Cards Aetna itself makes/uses infringing VISA systems as pled in complaint Aetna is a non-operating holding company; actions by subsidiaries Factual allegations sufficient and must be credited; issue remanded.
Sufficiency of indirect infringement (VISA Products) Complaint pleads plausible knowledge and intent to induce/contribute No specific direct infringer or intent detailed Allegations sufficient to state induced/contributory infringement claim.
Amendment of complaints Leave to amend denied due to presumed incurable deficiencies Plaintiff failed to cure defects in pleadings over multiple attempts Prior denial issues moot as viable claims were pled in operative complaint.

Key Cases Cited

  • Ashcroft v. Iqbal, 556 U.S. 662 (2009) (sets the plausibility and factual pleading standard for federal complaints)
  • Bell Atlantic Corp. v. Twombly, 550 U.S. 544 (2007) (sets the plausibility standard for Rule 12(b)(6) dismissal)
  • Centillion Data Sys., LLC v. Qwest Commc’ns. Int’l, Inc., 631 F.3d 1279 (Fed. Cir. 2011) (defines "use" of a system for patent infringement)
  • In re Bill of Lading Transmission & Processing Sys. Patent Litig., 681 F.3d 1323 (Fed. Cir. 2012) (standards for sufficiently pleading indirect infringement)
  • Macom Tech. Sols. Holdings, Inc. v. Infineon Techs. AG, 881 F.3d 1323 (Fed. Cir. 2018) (license as an affirmative defense to patent infringement)
  • Flex-Foot, Inc. v. CRP, Inc., 238 F.3d 1362 (Fed. Cir. 2001) (Federal Circuit law applies to patent enforcement procedure)
  • Disc Disease Sols. Inc. v. VGH Sols., Inc., 888 F.3d 1256 (Fed. Cir. 2018) (patent complaints need only put defendant on notice, not detailed element-by-element pleadings)
Read the full case

Case Details

Case Name: Alexsam, Inc. v. Aetna, Inc.
Court Name: Court of Appeals for the Federal Circuit
Date Published: Oct 8, 2024
Citations: 119 F.4th 27; 22-2036
Docket Number: 22-2036
Court Abbreviation: Fed. Cir.
Log In
    Alexsam, Inc. v. Aetna, Inc., 119 F.4th 27